AB DigiHealth(AB DigiHealth)
AB DigiHealth是從成大基因體醫學中心衍生成立,2021年推出「智慧優質胚胎預測系統(icONE)」,首創運用胚胎植入前遺傳學篩檢資料作為大數據基礎,並結合母親生理特徵共同分析,來判斷胚胎存活率和植入子宮後成功懷孕的機率,其預測胚胎成功著床的精準度可達92%,並已在2024年4月取得美國FDA的第一類軟體醫材(SaMD)認證。AB DigiHealth Inc. stands as a pioneering, modern core laboratory dedicated to advancing genomic research. Originating as a startup from Center for Genomic Medicine, National Cheng Kung University in Taiwan, our mission is to bridge the gap between scientific discoveries and clinical applications, providing a comprehensive solution for maternal-fetal precision medicine to the world.